Evidence map›Paper›PMID 16647042›Full record

ArticleBiochemical and biophysical research communications2006

Curcumin potently blocks Kv1.4 potassium channels.

Haiyan Liu, Sanjay J Danthi, John J Enyeart

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. The Influence of Phytoconstituents for the Management of Antipsoriatic Activity in Various Animal Models.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. Curcumin Acts as a Positive Allosteric Modulator ofThe Journal of pharmacology and experimental therapeutics · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Haiyan LiuDepartment of Neuroscience, The Ohio State University, College of Medicine and Public Health, Columbus, OH 43210-1239, USA.
Sanjay J Danthi
John J Enyeart
The Ohio State University · US

Funding

PROPERTIES OF K+ CURRENT THAT CONTROLS SECRETIONR01DK047875 · NIDDK · OHIO STATE UNIVERSITY · PI ENYEART, JOHN J · 1995 to 2008
$2.1M
NIDDK NIH HHS R01 DK047875NIDDK NIH HHS R01-DK47875
6 · The paper itself

Abstract

Curcumin, a major constituent of the spice turmeric, is a nutriceutical compound reported to possess therapeutic properties against a variety of diseases ranging from cancer to cystic fibrosis. In whole-cell patch-clamp experiments on bovine adrenal zona fasciculata (AZF) cells, curcumin reversibly inhibited the Kv1.4K+ current with an IC50 of 4.4 microM and a Hill coefficient of 2.32. Inhibition by curcumin was significantly enhanced by repeated depolarization; however, this agent did not alter the voltage-dependence of steady-state inactivation. Kv1.4 is the first voltage-gated ion channel demonstrated to be inhibited by curcumin. Furthermore, these results identify curcumin as one of the most potent antagonists of these K+ channels identified thus far. It remains to be seen whether any of the therapeutic actions of curcumin might originate with its ability to inhibit Kv1.4 or other voltage-gated K+ channel.

Indexed as

Adrenal GlandsAnimalsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsCattleCells, CulturedCurcuminInhibitory Concentration 50Kv1.4 Potassium ChannelPatch-Clamp TechniquesAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsCurcuminKv1.4 Potassium Channel

Identifiers

PMID16647042
PMCPMC2656109
OpenAlexW1995246085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.